Loading...
Despite their proven efficacy, contraceptive intrauterine devices (IUDs) and implants are still used by relatively few U.S. women. To determine if women initially seeking short-acting reversible contraception (SARC) would find IUDs and implants acceptable, investigators conducted a partially randomized 12-month patient preference trial involving >900 sexually active women (age range, 18–29). Participants agreeing to randomization were assigned to receive highly effective reversible contraception (intrauterine devices or subdermal implants) or SARC (oral contraception or injectable depot medroxyprogesterone acetate). Women who declined randomization selected their own form of SARC.
Among those women who consented to be randomized, 177 receive…